Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Acadia Healthcare (ACHC)

Acadia Healthcare cuts 2025 guidance as Q3 profit falls; revenue rises 4.4%

Negative Impact 4 of 5 guidance Written later

Acadia Healthcare reported third-quarter 2025 revenue of $851.6 million, up 4.4% year over year, but diluted earnings per share fell to $0.40 from $0.74 and adjusted EBITDA fell to $173.0 million from $194.3 million. The company lowered its full-year 2025 revenue, adjusted EBITDA and adjusted EPS guidance, and COO Dr. Nasser Khan resigned effective November 3, 2025.

Key points

  • Q3 revenue $851.6 million, up 4.4%; same-facility admissions up 3.3%
  • Net income attributable to Acadia $36.2 million, or $0.40 per diluted share, vs $0.74 a year earlier
  • Full-year adjusted EBITDA guidance cut to $650 million to $660 million from $675 million to $700 million
  • Dr. Nasser Khan resigned as COO effective November 3, 2025; receives a $515,000 lump-sum payment by March 15, 2026

The filing

CompanyAcadia Healthcare (ACHC)
Form8-K, current report
Filed with the SECNov 5, 2025, 4:11 PM ET
Accession number0001437749-25-033347

Items reported: 2.02 Results of Operations5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:39 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.